Mitochondrial dysfunction and abnormal accumulation of Aβ and Tau proteins can contribute to create the imbalance between oxidant and antioxidant mechanisms determining oxidative damage in AD patients [37]. This evidence concerns the gene MAPT and Alzheimer disease.